| Balance sheet (USD) | FY 2025 ended Mar 31, 2025 | FY 2024 ended Mar 31, 2024 | FY 2023 ended Mar 31, 2023 | FY 2022 ended Mar 31, 2022 | FY 2022 ended Mar 31, 2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 4.23M | 3.59M | 9.35M | 21.8K | 17.6K |
| Total assets | 6.43M | 5.48M | 9.81M | 48.7K | 39.6K |
| Total liabilities | 964.8K | 345.2K | 908.4K | 1.25M | 871.4K |
From Virax Biolabs Group Ltd's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.